National Health Investors, Inc. (NYSE:NHI) Receives Average Rating of “Moderate Buy” from Brokerages

National Health Investors, Inc. (NYSE:NHI) has received an average recommendation of “Moderate Buy” from the eight ratings firms that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among analysts that have covered the stock in the last year is $83.8571.

NHI has been the topic of several research reports. Cantor Fitzgerald restated an “overweight” rating and issued a $94.00 price target on shares of National Health Investors in a report on Wednesday, April 22nd. BMO Capital Markets dropped their price objective on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research report on Monday, June 15th. Zacks Research downgraded shares of National Health Investors from a “hold” rating to a “strong sell” rating in a research note on Thursday, June 25th. Weiss Ratings lowered shares of National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a report on Friday, June 12th. Finally, Truist Financial decreased their price target on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating for the company in a research report on Friday, June 12th.

National Health Investors Price Performance

NHI stock opened at $76.62 on Thursday. The company has a market cap of $3.71 billion, a PE ratio of 24.72, a price-to-earnings-growth ratio of 3.42 and a beta of 0.51. The company has a current ratio of 8.20, a quick ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a 50-day moving average price of $74.37 and a two-hundred day moving average price of $79.64. National Health Investors has a 12-month low of $67.94 and a 12-month high of $91.38.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Tuesday, June 30th. National Health Investors’s payout ratio is currently 118.71%.

Insider Activity

In related news, Director Robert A. Mccabe, Jr. bought 890 shares of the stock in a transaction dated Monday, June 15th. The stock was acquired at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the purchase, the director owned 44,159 shares in the company, valued at $3,163,992.35. This represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average price of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the acquisition, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The SEC filing for this purchase provides additional information. 2.70% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On National Health Investors

A number of large investors have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in National Health Investors in the 4th quarter valued at about $55,301,000. Freestone Grove Partners LP purchased a new position in National Health Investors in the fourth quarter valued at about $21,869,000. Adage Capital Partners GP L.L.C. acquired a new stake in National Health Investors during the 4th quarter valued at approximately $19,856,000. Balyasny Asset Management L.P. grew its stake in National Health Investors by 66.9% during the 2nd quarter. Balyasny Asset Management L.P. now owns 614,960 shares of the real estate investment trust’s stock valued at $43,121,000 after purchasing an additional 246,486 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in National Health Investors by 481.3% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 236,383 shares of the real estate investment trust’s stock worth $18,792,000 after purchasing an additional 195,716 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.